Selling companies to China and the USA – Still possible from a regulatory perspective?
By MRL Advisors Research Germany, as the EU’s largest economy, has revised and tightened its screening mechanisms for foreign direct investment (FDI) in recent years. Investments in key sectors such as AI, semiconductors, quantum computing and biotechnology were scrutinized with increased attention, particularly in response to global trends towards technological sovereignty. Does this mean the […]
MRL Advisors takes a stake in EMTS Group Pte. Ltd. in Singapore and Manila
By Frank-Christian Raffel EMTS – European Medtech Services – has set itself the goal of improving the availability of medical technology in Southeast Asia. MRL Advisors has joined as a founding partner. The former top manager of the Austrian Fresenius-VAMED, Matthias Köhler, had the idea to found the company when Southeast Asia was no longer […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]